How can PrEP support my practice?
Patient care providers around New Hampshire are seeking PrEP information daily. We know you're busy. Granite State PrEP Connect is here to make accessing all things PrEP easier with our FAQs section.
PrEP is short for pre-exposure prophylaxis. It is the use of antiretroviral medication to prevent acquisition of HIV infection. PrEP is used by people who are at risk of being exposed to HIV through sexual contact or injection drug use. At present, the only medication with an FDA-approved indication for PrEP is oral tenofovir disoproxil fumarate-emtricitabine (TDF-FTC), which is available as a fixed-dose combination in a tablet called Truvada. This medication is also commonly used in the treatment of HIV. PrEP should be considered part of a comprehensive prevention plan that includes adherence, risk reduction counseling, HIV prevention education and provision of condoms. Recently, a fixed-dose combination similar to Truvada, Descovy, was approved for HIV treatment; this pill includes a novel, tenofovir pro-drug (tenofovir alafenamide) in addition to emtricitabine.